Aukera Therapeutics
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$6.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aukera Therapeutics is a biotechnology company developing therapies for mTOR-related disorders such as tuberous sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aukera Therapeutics Comparables
Compare Aukera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aeovian Pharmaceuticals | 84% | |
| Cambrian Bio | 78% | |
| Johnson & Johnson | 74% | |
Aukera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Grant | Oct 19, 2022 | ||||
| Accelerator | Feb 21, 2022 |
Aukera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
$6M raised from Zurcher Kantonalbank and Kickfund.
- Feb 21, 2022
$540K raised from BaseLaunch
Aukera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aukera Therapeutics's valuation, stock price, and market status.